🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of acetaminophen, claiming the companies concealed potential risks that the medication presented to pediatric brain development.

The lawsuit arrives a month after President Donald Trump advocated an unsubstantiated connection between using Tylenol - alternatively called paracetamol - throughout gestation and autism spectrum disorder in children.

The attorney general is suing the pharmaceutical giant, which once produced the drug, the only pain reliever approved for women during pregnancy, and Kenvue, which currently produces it.

In a declaration, he said they "deceived the public by gaining financially from discomfort and pushing pills without regard for the potential hazards."

Kenvue says there is insufficient reliable data connecting Tylenol to autism.

"These manufacturers misled for generations, deliberately risking countless individuals to line their pockets," the attorney general, from the Republican party, declared.

The company stated officially that it was "very worried by the spread of false claims on the safety of paracetamol and the likely effects that could have on the well-being of American women and children."

On its official site, Kenvue also said it had "consistently assessed the pertinent research and there is insufficient valid information that indicates a verified association between consuming acetaminophen and autism spectrum disorder."

Groups representing physicians and health professionals concur.

ACOG has declared acetaminophen - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to address pain and elevated temperature, which can present serious health risks if ignored.

"In more than two decades of studies on the utilization of acetaminophen in gestation, not a single reputable study has successfully concluded that the consumption of acetaminophen in any period of pregnancy causes brain development issues in offspring," the group stated.

This legal action references current declarations from the Trump administration in claiming the medication is allegedly unsafe.

Last month, the former president caused concern from health experts when he instructed expectant mothers to "fight like hell" not to use Tylenol when ill.

Federal regulators then issued a notice that physicians should think about restricting the usage of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in children has not been established.

Health Secretary RFK Jr, who manages the Food and Drug Administration, had pledged in spring to initiate "a massive testing and research effort" that would establish the source of autism spectrum disorder in a limited time.

But specialists advised that finding a unique factor of autism - thought by researchers to be the outcome of a complex mix of genetic and external influences - would be difficult.

Autism is a category of enduring cognitive variation and condition that affects how people perceive and engage with the world, and is diagnosed using medical professional evaluations.

In his lawsuit, the attorney general - aligned with the former president who is seeking the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the research" around paracetamol and autism.

The case attempts to require the companies "destroy any commercial messaging" that states acetaminophen is safe for pregnant women.

This legal action parallels the complaints of a collection of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in 2022.

Judicial authorities dismissed the legal action, stating research from the plaintiffs' authorities was inconclusive.